Your browser doesn't support javascript.
loading
Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection.
Seow, Jeffrey; Shalim, Zayed A; Graham, Carl; Kimuda, Simon; Pillai, Aswin; Lechmere, Thomas; Kurshan, Ashwini; Khimji, Atika M; Snell, Luke B; Nebbia, Gaia; Mant, Christine; Waters, Anele; Fox, Julie; Malim, Michael H; Doores, Katie J.
Afiliação
  • Seow J; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom.
  • Shalim ZA; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom.
  • Graham C; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom.
  • Kimuda S; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom.
  • Pillai A; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom.
  • Lechmere T; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom.
  • Kurshan A; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom.
  • Khimji AM; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom.
  • Snell LB; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom.
  • Nebbia G; Department of Infectious Diseases, Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust , London, United Kingdom.
  • Mant C; Department of Infectious Diseases, Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust , London, United Kingdom.
  • Waters A; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom.
  • Fox J; Department of Infectious Diseases, Infectious Diseases Biobank, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom.
  • Malim MH; Harrison Wing, Guy's and St Thomas' NHS Foundation Trust , London, United Kingdom.
  • Doores KJ; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom.
mBio ; 14(5): e0120623, 2023 Oct 31.
Article em En | MEDLINE | ID: mdl-37747187
ABSTRACT
IMPORTANCE With the emergence of SARS-CoV-2 viral variants, there has been an increase in infections in vaccinated individuals. Here, we isolated monoclonal antibodies (mAbs) from individuals experiencing a breakthrough infection (Delta or BA.1) to determine how exposure to a heterologous Spike broadens the neutralizing antibody response at the monoclonal level. All mAbs isolated had reactivity to the Spike of the vaccine and infection variant. While many mAbs showed reduced neutralization of current circulating variants, we identified mAbs with broad and potent neutralization of BA.2.75.2, XBB, XBB.1.5, and BQ.1.1 indicating the presence of conserved epitopes on Spike. These results indicate that variant-based vaccine boosters have the potential to broaden the vaccine response.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Infecções Irruptivas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: MBio Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Infecções Irruptivas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: MBio Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido